Revvity, Inc. Overview
Pro stress-test →Revvity is an American company in the life sciences and diagnostics business focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health.
Strategic Profile
Pro stress-test →The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023, marking a transformation aimed at strengthening its market position as a translational solutions provider. Revvity serves pharmaceutical and biotech, clinical labs, academia, and governments worldwide.
Competitive Landscape
Pro stress-test →In life sciences, Revvity competes with Thermo Fisher Scientific, Agilent Technologies, and Danaher Corporation in analytical instrumentation, imaging systems, and laboratory automation. In diagnostics, the company faces competition from Abbott Laboratories, Roche Holding, and Siemens Healthineers in newborn screening and prenatal testing.
Industry Context
Revvity, Inc. operates in Life Sciences and Diagnostics.
Key facts
Founded: 1937 · Headquarters: Waltham, Massachusetts · Revenue: $2.86B · Market cap: $11.8B